Pre-menopause
Cycles are regular but rarely silent. We map oestradiol and progesterone across the follicular and luteal phases, alongside iron, thyroid, and PCOS markers - the foundation for the next thirty years.
Built for the way women's biology actually works.
Phase-aware diagnostics, evidence-based protocols, and care that adapts to where you are in life - not where a textbook says you should be.
Proactive, not reactive
Conventional medicine waits for disease and treats symptoms. We map biology while there's still room to change the trajectory - especially across the hormonal transitions that shape the second half of a woman's life.
Data → DecisionData over intuition
Every clinical decision begins with measurement. Bloodwork, DEXA, fitness assessments and validated questionnaires create a full picture of your biology before anything is recommended.
Phase-awareContext, not “normal”
A generic reference range tells you whether you sit inside a wide statistical band. We read your results against your life stage and, where it matters, your cycle phase - so a number actually means something for you.
Whole pictureStack, don't sequence
Hormones don't sit alone. Iron, thyroid, gut, sleep, inflammation and metabolic markers are read together — because the symptoms women are most often dismissed for live in the connections.
Three biologies, not one
A woman's body operates on three distinct biological baselines across her life. Most healthcare treats all three as a single “normal”. We don't.
Peri-menopause
The noisy middle. Hormones fluctuate unpredictably for four to ten years before they settle — which is exactly the period when most symptoms are missed or misattributed. A single test isn’t enough; we map the pattern.
Post-menopause
A new baseline, with new priorities - cardiovascular, bone, metabolic and cognitive health move to centre stage. We build a protocol around what your body actually needs now, not what it needed a decade ago.
The assessment, the reference ranges and the protocol Cue builds for you depend on which biology you are in right now — not a single curve.
Hundreds of data points. One assessment.
Blood, body composition, fitness and validated questionnaires — read against stage- and phase-aware reference ranges. Every result reviewed by a Cue doctor before it reaches you.
Hormonal panel
22 markersMetabolic & cardiovascular
18 markersGut microbiome
41 markersBody composition & fitness
9 markers
Hormonal panel
Phase-aware estrogen, progesterone, testosterone (total & free), DHEA-S, SHBG, FSH, LH, AMH, prolactin, cortisol rhythm, TSH, free T3/T4.
Watch the pattern emerge
One score is a snapshot. Three months of scores is a pattern. A year is a story. Each retest sharpens the picture — what's shifting, what's responding to your plan, what still needs attention.
Built on science, not trends
Every protocol at Cue is grounded in peer-reviewed research, with a particular focus on the studies most relevant to women — who have historically been underrepresented in cardiovascular and metabolic research.
Women develop ischaemic heart disease about ten years later than men, but present and are treated later even with the same symptoms — contributing to higher mortality despite lower prevalence.
Maas A et al., Lancet Reg Health Eur 2025·Wickramatilake CM et al., NHANES 2001-2020
The Study of Women's Health Across the Nation (SWAN) shows hot flushes and night sweats occur in up to 80% of women through the menopausal transition — yet most are told their bloods look normal.
Harlow SD et al., SWAN - Menopause 2019·Greendale GA et al., J Bone Miner Res 2012
Women lose up to 10% of spine bone density across the three years around the final menstrual period. DEXA-tracked early intervention is one of the most reliable ways to protect long-term skeletal health.
Greendale GA et al., J Bone Miner Res 2012·SWAN bone substudy
Apolipoprotein B captures atherogenic particle count directly — a more accurate predictor of cardiovascular events than LDL cholesterol alone, and increasingly central to risk assessment in women after menopause.
Sniderman et al., Lancet 2019·Mora et al., JACC 2020·Nordestgaard et al., EHJ 2010
Three tiers, working together
Most clinics try one intervention at a time and wait months between adjustments. We start where there's most to gain, and bring lifestyle, supplementation and medical interventions together when the evidence supports it — not in a fixed sequence.
Foundation
Lifestyle Architecture
Specific, measurable targets calibrated to your sleep, movement, nutrition and stress regulation — written as protocols, not generic advice.
Targeted
Evidence-Based Supplementation
Every supplement prescribed with a clear medical rationale tied to your biomarker profile. No kitchen-sink stacks — only what the evidence supports for you.
Medical
Hormone therapy and medication
When indicated, hormone therapy and other medications are initiated under direct physician oversight — with strict clinical indications, ongoing monitoring, and referral to gynaecology, cardiology or endocrinology when needed.
Care designed for Her
A side-by-side look at how Cue's approach differs from a conventional check-up — particularly when it comes to the questions women in their 40s, 50s and beyond bring through the door.
Cue
- Phase-aware hormonal mapping
- Reference ranges by life stage and cycle phase
- Bone, cardiovascular, and metabolic markers tracked from peri- onward
- Plan adjusted every three months
- Specialists brought in when needed
- Continuous physician oversight
Traditional clinic
- One-time hormone snapshot
- Single-population reference range
- Symptoms attributed to "age"
- Annual or as-needed only
- Self-navigated specialist referrals
- Limited follow-up
Physician-led. Always.
Cue is not a wellness brand with a medical advisor. It's a physician-founded clinical platform where every protocol, every prescription, and every patient interaction is under direct medical oversight and operates in accordance with Styrelsen for Patientsikkerhed.
Chief Medical Officer
Laura Kassem, M.D.
Physician leading Cue's medical direction across product, operations and care delivery. MD, PhD researcher at Rigshospitalet, with clinical responsibility for Cue Her and oversight of clinical quality, safety and outcomes.